[Comment] Genotype-based antimicrobial resistance tests need a new regulatory framework | ClinicLens
Antimicrobial resistance (AMR) is eroding the effectiveness of antibiotics and raising the cost of incorrect empirical therapy. Sequence-based diagnostics that infer antimicrobial susceptibility from pathogen genomes promise faster, more tailored prescribing than culture-based su
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.